least in XIENCE with significant difference compared to BioMatrix Flex (p< 0.001) and Synergy (p< 0.001). Conclusions: The current ex vivo swine shunt model demonstrated the least thrombogenicity in permanent polymer XIENCE as compared to 4 biodegradable polymer DES, which emphasizes its acute protective effect against thrombus formation.
Conclusions: SAP was associated with slightly higher CL and reduced MV area, but induced higher stresses on the mitral annulus. TMA resulted in an effective improvement of valve competence while avoiding mechanical overloads. These promising outcomes are under further clinical evaluation.
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Acute and chronic effects of cryotherapy on atherosclerotic plaque composition in the thoracic aorta of cholesterol-fed rabbits: a potential solution for treatment of plaques Background: Atherosclerotic plaque rupture remains the leading cause of acute cardiovascular syndromes and the need for plaque stabilizing interventions is high. In the last 10 years, cryotherapy was investigated as a new technology to treat vascular disease. Previous studies focused mainly on treatment and prevention of restenosis in peripheral arterial disease. The efficiency of cryotherapy on stabilizing atherosclerotic plaques has never been described. The purpose of the present study was to evaluate the effect of catheter-based cryotherapy on atherosclerotic plaque composition in a rabbit model of atherosclerosis. Methods: Twenty-four New-Zealand White rabbits were fed a 0.3%-cholesterol supplemented diet for 24 weeks. At three predefined sites of the atherosclerotic thoracic aorta, balloon angioplasty applying either single dose, double dose cryotherapy or control inflation was performed. Rabbits were continued on cholesterol-supplemented diet for 1 day (acute) or 4 weeks (chronic). After euthanasia and preparation for histology, sections were analyzed for apoptosis, content of smooth muscle cells (SMC), collagen, and macrophages, endothelium and calcifications. Results: One day after cryotherapy, apoptotic cell death of SMCs and endothelial cells (ECs) was observed, whereas macrophages were unaffected. Four weeks after cryo-treatment, the amount of SMCs was restored and the EC layer was regenerated. Moreover, the thickness and type I collagen content of the fibrous cap was increased, indicative of a more stable plaque. The percentage of macrophages was slightly increased in deep layers, but unaltered in luminal layers of the plaque. The frequency of plaque calcifications was increased and signs of positive remodeling were observed. Conclusions: For the first time in atherosclerotic lesions, this present study demonstrated that cryotherapy is safe and appears to stabilize atherosclerotic plaques in a rabbit model. This warrants further investigation. Background: The Multilayer Flow Modulator (MFM) (Cardiatis, Isnes, Belgium) is a self-expandable mesh of cobalt alloy wires used for the treatment of aortic aneurysms. We assessed the impact of design thread count and duration of implantation on the biocompatibility of the MFM in porcine animal models. Methods: Eight mini-piglets received 26 MFM (12 with 56 thread design, 14 with 80 or 96 threads) in iliac, carotid, and renal arteries. Animals were sacrificed/ explanted at 1, 3, and 6 months, when histological and ultrastructural analyses were conducted. Results: The MFM was successfully deployed in 25 of 26 cases. Percentage stenosis was 16.9% AE 5.1% for the 56 thread devices versus 33.4% AE 10.2% for the 80-96 thread devices (p ¼ 0.001) at 3 months, and 21.7% AE 9.9% for the 56 thread devices versus 33.6% AE 12.4% for the 80-96 thread devices (p ¼ 0.004) at 6 months. The 5 devices selected for SEM examination were well deployed, integrated into the vessel wall and endothelialized (Figure 1) , and had patent side branches.
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